ProSomnus Sleep Technologies

Call Directions Website Contact the practice

ProSomnus Sleep Technologies ProSomnus intraoral medical devices are engineered to precisely track the treatment plan and anatomy for each patient. To learn more, visit www.ProSomnus.com.

ProSomnus® is the pioneer and global leader in Smart Sleep Medicine™, delivering precision, non-CPAP Oral Appliance Therapy for Obstructive Sleep Apnea (OSA), with integrated multi-night physiologic monitoring enabled by its RPMO₂ platform. ProSomnus (NASDAQ: OSA) is a leading CPAP alternative for the treatment of Obstructive Sleep Apnea, a serious medical disease affecting over 1 billion people worldwide, that is associated with comorbidities including heart failure, stroke, hypertension, morbid obesity, and type 2 diabetes. Non-invasive, patient preferred and easy to use, ProSomnus devices have demonstrated excellent efficacy, safety, adherence, and overall outcomes in a growing body of clinical investigations. ProSomnus precision intraoral devices are FDA-cleared, patented, and covered by commercial medical insurance, Medicare, TRICARE and many Government sponsored healthcare plans around the world, representing over 200 million covered lives.

JOIN US for a live to explore the latest ProSomnus Sleep Technologies RPMO₂ platform enhancements designed to deliver ...
10/22/2026

JOIN US for a live to explore the latest ProSomnus Sleep Technologies RPMO₂ platform enhancements designed to deliver deeper clinical insights and improved practice efficiency.

LEARNING OBJECTIVES:
• Interpret RPMO₂'s new hypoxic burden metrics and understand their role in assessing OSA severity and treatment response.
• Utilize head position monitoring data to evaluate position-dependent sleep-disordered breathing and support personalized treatment decisions.
• Leverage enhanced RPM billing support tools to improve documentation, workflow efficiency, and reimbursement readiness.
• Understand new firmware management capabilities designed to maintain device performance, security, and access to platform innovations.
• Apply RPMO₂ platform enhancements to optimize patient monitoring and practice operations.

FEATURING:
Edward T. Sall, MD, DDS, MBA
Mark T. Murphy, DDS, D.ABDSM, FAASM, FAGD
🗓️ Wednesday, November 4, 2026
5:00 PM Pacific Time

👉 LEARN MORE & REGISTER TODAY
https://tinyurl.com/5csv5byb

🌟 Meet the leaders helping shape the future of sleep medicine. 🌟 The newly formed ProSomnus Sleep Technologies Medical A...
10/22/2026

🌟 Meet the leaders helping shape the future of sleep medicine. 🌟

The newly formed ProSomnus Sleep Technologies Medical Advisory Board brings together nine globally recognized experts whose collective expertise spans clinical care, research, technology, and innovation in sleep medicine.

Their strategic guidance will help accelerate advancements that improve patient outcomes and expand access to effective OSA treatment.

Today, we're honored to spotlight three of these distinguished experts. ⬇️

LEE A. SURKIN, MD, FACC, FCCP, FASNC, FAASM
Founder, American Academy of Cardiovascular Sleep Medicinea
--
OLIVIER M. VANDERVEKEN, MD, PHD
Professor of Medicine, University of Antwerp, Belgium
--
ADRIAN J. WILLIAMS, MBBS, FRCP, FAASM
Professor of Sleep Medicine, at King’s College London
--

Nine exceptional leaders. One shared vision: advancing sleep medicine and improving patient outcomes.


CHEST 2026: A strong finish and a clear vision forward.Great conversations, fresh perspectives, and a shared commitment ...
10/21/2026

CHEST 2026: A strong finish and a clear vision forward.

Great conversations, fresh perspectives, and a shared commitment to advancing sleep medicine made American College of Chest Physicians (CHEST) 2026 valuable. We enjoyed connecting with professionals who visited the ProSomnus Sleep Technologies team and joined Dr. Xzavier Ozuna’s poster presentation.

The REST-OA study results led by Dr. Ozuna indicate that oral appliance therapy using the ProSomnus EVO Guided device can successfully reduce AHI and hypoxic burden across a broad range of BMI, including class II and III obesity.

CHEST 2026 reinforced the growing role of precision oral appliance therapy and data-driven innovation in advancing sleep medicine.

The key takeaway: More precise, personalized, and measurable approaches are shaping the future of OSA treatment.

✨ Smart Sleep Medicine™ ✨

🌟 Meet the leaders helping shape the future of sleep medicine. 🌟 The newly formed ProSomnus Sleep Technologies Medical A...
10/21/2026

🌟 Meet the leaders helping shape the future of sleep medicine. 🌟

The newly formed ProSomnus Sleep Technologies Medical Advisory Board brings together nine globally recognized experts whose collective expertise spans clinical care, research, technology, and innovation in sleep medicine.

Their strategic guidance will help accelerate advancements that improve patient outcomes and expand access to effective OSA treatment.

Today, we're honored to spotlight three of these distinguished experts. ⬇️

DAVID M. RAPOPORT, MD
Professor of Medicine, Icahn School of Medicine at Mount Sinai
--
EDWARD T. SALL, MD, DDS, MBA
Medical Director, ProSomnus Sleep Technologies
--
AMIR SHARAFKHANEH, MD, PHD
Professor of Medicine, Baylor College of Medicine
--

Join us throughout the week as we introduce all nine distinguished leaders helping shape the future of sleep medicine.


🌟 Meet the leaders helping shape the future of sleep medicine. 🌟 The newly formed ProSomnus Sleep Technologies Medical A...
10/20/2026

🌟 Meet the leaders helping shape the future of sleep medicine. 🌟

The newly formed ProSomnus Sleep Technologies Medical Advisory Board brings together nine globally recognized experts whose collective expertise spans clinical care, research, technology, and innovation in sleep medicine.

Their strategic guidance will help accelerate advancements that improve patient outcomes and expand access to effective OSA treatment.

Today, we're honored to spotlight three of these distinguished experts. ⬇️

DANNY J. ECKERT, PHD
Director, Flinders Health and Medical Research Institute Flagship Sleep Health Program, Flinders University, Australia
--
DANIEL J. GOTTLIEB, MD, MPH
Associate Professor of Medicine, Harvard Medical School
--
SANJAY R. PATEL, MD, MS, ATSF, FAASM
Professor of Medicine and Epidemiology, University of Pittsburgh
--

Join us throughout the week as we introduce all nine distinguished leaders helping shape the future of sleep medicine.


Rethink what’s possible in OSA care.Connect with the ProSomnus Sleep Technologies team to explore how Smart Sleep Medici...
10/20/2026

Rethink what’s possible in OSA care.

Connect with the ProSomnus Sleep Technologies team to explore how Smart Sleep Medicine™ will change the way you treat OSA, objective insights into treatment effectiveness, and the following presentation by Dr Erin Mosca:

🔹ABSTRACT
Validation of oxygen desaturation event detection by a buccal mucosal oximeter.

---

🔹ORAL PRESENTATION ASSIGNMENT INFORMATION
Oral Session 8: State-of-the-art Developments in Sleep Monitoring
Session Start—End:
21.10.2026, 08:30:00 - 09:30:00
Presentation Start—End:
21.10.2026, 09:18:00 - 09:30:00

---

🔹PAPER POSTER PRESENTATION
Poster Board / Area #1
12:30 – 13:30 CEST

---

We look forward to connecting with you at the European Sleep Research Society - ESRS Congress.
📍 Masstricht, Nederlands | Booth A64
📅 October 20-23


JUST RELEASEDWorld-Renowned Sleep Medicine Leaders Join ProSomnus Medical Advisory Board, RPMO₂ Enhancements, Published ...
10/19/2026

JUST RELEASED
World-Renowned Sleep Medicine Leaders Join ProSomnus Medical Advisory Board, RPMO₂ Enhancements, Published FLOSAT Study Results, and Scientific Contributions at CHEST 2026.

Access report here: https://tinyurl.com/3t2aa6r3

What happens when Oral Appliance Therapy meets real-time data? Our ProSomnus Sleep Technologies team will be on site at ...
10/16/2026

What happens when Oral Appliance Therapy meets real-time data?

Our ProSomnus Sleep Technologies team will be on site at the American College of Chest Physicians (CHEST) 2026 Annual Annual Meeting. We look forward to connecting with attendees and sharing how Smart Sleep Medicine™ is helping advance the future of sleep apnea treatment.

STOP BY OUR BOOTH #1100 TO LEARN ABOUT:
🔹 Clinical evidence demonstrating that EVO® is non-inferior to CPAP(1)
🔹 Real-world outcomes with ProSomnus OAT
🔹 Smart Sleep Medicine innovations, including EVO® Guided and RPMO2
🔹 Data-driven titration with integrated oximetry
🔹 RPMO2 coding and reimbursement insights

(1)doi: 10.1093/ajrccm/aamag388

📍 CHEST | Phoenix, AZ | 📅 October 19-21

POSTER PRESENTATION Q&A
Tuesday, Oct 20 | 1:45 PM—2:30 PM

P3218: Late-Breaking Scientific Abstract Posters (B): Pulmonary Vascular Disease, Sleep Disorders; Xzavier Ozuna, DBA, PfMP, CCRP, BC-MAS (Star Sleep & Wellness, Texas)



Can objective data redefine how we evaluate oral appliance therapy? Our ProSomnus Sleep Technologies team will be on sit...
10/15/2026

Can objective data redefine how we evaluate oral appliance therapy?

Our ProSomnus Sleep Technologies team will be on site at the American Academy of Cardiovascular Sleep Medicine (AACSM) 2026 Scientific Conference. We look forward to connecting with attendees and sharing how Smart Sleep Medicine™ is advancing oral appliance therapy through objective physiologic data, measurable outcomes, and evidence-based clinical decision-making.

Stop by our table to learn about:
🔹 Clinical evidence demonstrating that EVO® is non-inferior to CPAP(1)
🔹 Real-world outcomes with ProSomnus OAT
🔹 Smart Sleep Medicine innovations, including EVO® Guided and RPMO2
🔹 Data-driven titration with integrated oximetry
🔹 RPMO2 coding and reimbursement insights

(1)doi: 10.1093/ajrccm/aamag388

📍 AACSM | Richmond, VA | 📅 October 15

What happens when Oral Appliance Therapy meets real-time data? Our ProSomnus Sleep Technologies team will be on site at ...
10/14/2026

What happens when Oral Appliance Therapy meets real-time data?

Our ProSomnus Sleep Technologies team will be on site at the American College of Chest Physicians CHEST 2026 Annual Annual Meeting. We look forward to connecting with attendees and sharing how Smart Sleep Medicine™ is helping advance the future of sleep apnea treatment.

Stop by space #1100 to learn about:
🔹 Clinical evidence demonstrating that EVO® is non-inferior to CPAP(1)
🔹 Real-world outcomes with ProSomnus OAT
🔹 Smart Sleep Medicine innovations, including EVO® Guided and RPMO2
🔹 Data-driven titration with integrated oximetry
🔹 RPMO2 coding and reimbursement insights

(1)doi: 10.1093/ajrccm/aamag388

📍 CHEST | Phoenix, AZ | 📅 October 19-21



Address

5675 Gibraltar Drive
Pleasanton, CA
94588

Opening Hours

Monday 6am - 5pm
Tuesday 6am - 5pm
Wednesday 6am - 5pm
Thursday 6am - 5pm
Friday 6am - 5pm

Telephone

+18445375337

Website

Alerts

Be the first to know and let us send you an email when ProSomnus Sleep Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ProSomnus Sleep Technologies:

Shortcuts

Share

Category